Archives
-
Olsalazine and Organic Cation Transport in Aedes
2026-08-16
Kennel and Rouhier’s 2025 study examines how Aedes aegypti mosquitoes excrete three injected xenobiotics and whether exposure alters six putative organic cation transporter transcripts. Its central finding is a disconnect between relatively stable transporter mRNA profiles and strong chemical-structure-dependent changes in excretion and mortality, highlighting the need to study transporter function rather than expression alone.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-08-15
Use the ECL Chemiluminescent Substrate Detection Kit (Enhanced) to resolve low-abundance signaling proteins in RCC western blots, from phospho-EGFR/ERK measurements to MMP9 and FGF2 validation. This workflow combines sensitive chemiluminescence, low background, and flexible imaging with practical controls for avoiding saturation, nonspecific signal, and weak bands.
-
How Kinase Inhibitors Tune p38α Dephosphorylation
2026-08-14
The reference preprint shows that some kinase inhibitors do more than block catalysis: they shift p38α into an activation-loop conformation that allows WIP1 to remove the activating phospho-threonine more efficiently. Biochemical comparisons and X-ray structures support a dual-action model, while the preprint status and in vitro design define important limits for therapeutic extrapolation.
-
15-PGDH Inhibition Preserves Muscle During Weight Loss
2026-08-14
A 2026 PNAS study identifies 15-PGDH inhibition as a strategy for improving muscle repair and force recovery during semaglutide-associated weight loss. In obese mice, combining a 15-PGDH inhibitor with semaglutide improved regenerative myofiber growth and muscle strength without negating weight reduction, providing a mechanistic framework for studying muscle quality during GLP-1 receptor agonist therapy.
-
Ceftazidime: From Assay Signal to Resistance Insight
2026-08-13
Ceftazidime is a third-generation cephalosporin with particular value in Gram-negative bacterial infection research. This article shows how its phenotypic activity can be integrated with plasmid localization, gene-transfer testing, and strain typing to interpret resistance more rigorously.
-
Autophagy, Lipid Breakdown, and Lipotoxicity in Salmon Cells
2026-08-13
A 2025 study in Atlantic salmon SHK-1 cells shows that rapamycin-induced autophagy promotes lipid-droplet turnover and reduces features of lipid overload. Integrated lipidomics and proteomics identify altered triacylglycerol storage and possible autophagic handling of Elovl6 and Fabp2, providing a mechanistic framework for studying fish lipid health.
-
CUX2 Neuron Loss from DNA Damage in Neuroinflammation
2026-08-12
Morcom and colleagues identify DNA damage burden and inadequate double-strand break repair as drivers of selective CUX2-positive layer 2/3 neuron loss during neuroinflammation. By integrating human multiple sclerosis tissue, mouse inflammatory models, neuronal genetic analysis, and interferon-γ experiments, the study connects inflammatory oxidative stress to cell-type-specific neuronal vulnerability.
-
VX-702: Rethinking Precision in p38α MAPK Research
2026-08-12
A mechanism-first perspective on VX-702 as a selective p38α MAPK inhibitor, connecting biochemical selectivity with cytokine biology, arthritis and cardiovascular models, assay design, and translational decision-making.
-
12-O-tetradecanoyl phorbol-13-acetate in PKC Assays
2026-08-11
12-O-tetradecanoyl phorbol-13-acetate (TPA) provides a controllable PKC-to-ERK stimulus for pathway validation, kinase assays, and cancer-model experiments. This guide converts that mechanism into a practical workflow while showing how the reference study’s mixed-microbe and NETs design can inspire, but not substitute for, TPA validation.
-
SLU-PP-332: Practical ERR Agonist Workflows
2026-08-11
Learn how to use SLU-PP-332 as an ERRα ERRβ ERRγ agonist in mitochondrial respiration, skeletal-muscle, and metabolic research. This workflow-focused guide emphasizes concentration design, orthogonal readouts, formulation control, and troubleshooting rather than unsupported therapeutic dosing.
-
Sulfisomidine: From Clinical History to Assay Design
2026-08-10
Sulfisomidine is a dual-purpose research compound linking bacterial folate disruption with hPON1 inhibition. This article transforms historical pharmacology and product specifications into a practical framework for enzyme assays, controls, and cross-domain interpretation.
-
O-propargyl-puromycin (OPP) for Protein Synthesis
2026-08-09
O-propargyl-puromycin (OPP) converts short translation pulses into measurable fluorescent or affinity-tagged signals, making global protein synthesis accessible in cells, tissues, and lysates. This guide translates recent B cell mitochondrial research into practical OPP workflows, assay controls, optimization steps, and troubleshooting decisions.
-
TRPV1 and TRPA1 Drive TSLP in Nasal Epithelium
2026-08-08
The reference study shows that TRPV1 and TRPA1 are expressed by nasal epithelial cells and connect environmental sensing to TSLP production through calcium-dependent NFAT signaling. Its combination of pharmacological activation, inhibition, calcium manipulation, and gene-silencing experiments provides a useful framework for studying epithelial contributions to upper-airway inflammation.
-
Cholesterol in mRNA-LNP Assay Design
2026-08-07
Cholesterol is more than a structural lipid: it is a controllable variable linking membrane biophysics, formulation quality, and localized mRNA-LNP performance. This guide translates recent intravesical p21-LNP findings into practical assay and handling decisions for researchers.
-
Direct Mouse Genotyping Kit: Precision PCR from Tissue to In
2026-08-07
Discover how the Direct Mouse Genotyping Kit enables rapid PCR amplification from mouse tissue, streamlining high-throughput genotyping for biomedical research. This article uniquely explores molecular mechanisms and practical assay optimization, offering a deeper perspective than existing resources.